C-Path’s TRxA Announces its First Global Request for Proposals from Academic Investigators Working to Advance Drug Development Projects

Launched in 2022, the Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients. TRxA is now accepting applications for its 2023 funding cycle.Continue reading